- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Pharma products in pipeline for top 10 diseases in developing countries 2016
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Pharma products in pipeline for top 10 diseases in developing countries 2016
Number of products in pharmaceutical industry pipeline for selected diseases in developing countries as of 2016
by Statista Research Department,
last edited
Nov 14, 2016
This statistic displays the top targeted diseases by number of products in the overall pharmaceutical industry pipeline, with a special focus on the needs of developing countries, as of 2016. At this time, there were 35 products along the pipeline dedicated to treating malaria. Most products currently being developed are for infectious diseases. These figures represent the market opportunity and medical needs for these specific medications.
Number of products in pharmaceutical industry pipeline for selected diseases in developing countries as of 2016
| Number of products | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Number of products | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Statista Research Department,
last edited
Nov 14, 2016
This statistic displays the top targeted diseases by number of products in the overall pharmaceutical industry pipeline, with a special focus on the needs of developing countries, as of 2016. At this time, there were 35 products along the pipeline dedicated to treating malaria. Most products currently being developed are for infectious diseases. These figures represent the market opportunity and medical needs for these specific medications.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- November 2016
- Region
- Worldwide
- Survey time period
- 2016
- Open this statistic in...
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- November 2016
More information
- Region
- Worldwide
- Survey time period
- 2016
- Open this statistic in...
Other statistics on the topic
Malaria
+Pharmaceutical Products & Market
Revenue of top 20 respiratory brands in the U.S. 2016
+State of Health
Global death rate - leading causes 2016
Pharmaceutical Products & Market
Distribution of global respiratory therapy market by condition 2017-2018
State of Health
U.S. states with highest adult smoking rates 2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Malaria
- 53 page/s
- English
- pptx
- Detailed references
Everything On "Malaria" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Chronic Obstructive Pulmonary Disease (COPD) in the U.S. "
- Global overview
The most important statistics
- Leading causes of death worldwide in 2016 (in millions)Global death rate - leading causes 2016
- Number of deaths from Chronic Obstructive Pulmonary Disease worldwide in 2015, by region (in thousands)Number of global COPD deaths in 2015, by region
- Percentage change in the number of deaths from Chronic Obstructive Pulmonary Disease worldwide from 1990 to 2015, by regionChange in number of global COPD deaths from 1990 to 2015, by region
- Number of prevalent cases of Chronic Obstructive Pulmonary Disease worldwide in 2015, by region (in thousands)Number of global COPD cases in 2015, by region
- Distribution of global respiratory therapy market by condition in 2017-2018 (in billion U.S. dollars)*Distribution of global respiratory therapy market by condition 2017-2018
- Number of products in pharmaceutical industry pipeline for selected diseases in developing countries as of 2016Pharma products in pipeline for top 10 diseases in developing countries 2016
- U.S. overview
The most important statistics
- Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2017, by stateCOPD prevalence in the U.S. 2017, by state
- Percentage of adults in the U.S. who had been diagnosed with Chronic Obstructive Pulmonary Disease as of 2015, by ethnicityShare of adults with COPD in the U.S. 2015, by ethnicity
- Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2015, by urban-rural statusCOPD prevalence in the U.S. 2015, by urban-rural status
- 30-day hospital readmission rates in the U.S. from 2015 to 2017, by selected disease*Readmission rates within 30-days in U.S. hospitals by disease 2015-2017
- Top 20 respiratory brands in the U.S. based on revenue in 2016 (in million U.S. dollars)Revenue of top 20 respiratory brands in the U.S. 2016
- Symptoms
The most important statistics
- Percentage of individuals in the U.S. with Chronic Obstructive Pulmonary Disease who experienced select symptoms within the last month as of 2017Symptoms experienced in the past month by individuals in the U.S. with COPD in 2017
- Percentage of individuals in the U.S. with COPD who stated select symptoms were the most challenging/frustrating as of 2017Most challenging symptoms for individuals in the U.S. with COPD in 2017
- Percentage of individuals in the U.S. with Chronic Obstructive Pulmonary Disease who stated it was easy to avoid triggers as of 2017Ease of avoiding COPD triggers among individuals in the U.S. with the disease in 2017
- Percentage of individuals in the U.S. with Chronic Obstructive Pulmonary Disease who experience incontinence when a flare-up hits as of 2017Incontinence during COPD flare-ups among individuals in the U.S. in 2017
- Deaths
The most important statistics
- Number of deaths from Chronic Obstructive Pulmonary Disease (COPD) among adults in the U.S. from 2000 to 2014, by gender (per 100,000 population)COPD death rate among U.S. adults from 2000 to 2014, by gender
- Number of deaths from Chronic Obstructive Pulmonary Disease (COPD) among adults in the U.S. from 2000 to 2014, by ethnicity (per 100,000 population)COPD death rate among U.S. adults from 2000 to 2014, by ethnicity
- Number of deaths from Chronic Obstructive Pulmonary Disease (COPD) among older adults in the U.S. in 2014, by age and gender (per 100,000 population)COPD death rate among older U.S. adults in 2014, by age and gender
- Distribution of leading underlying causes of death for Chronic Obstructive Pulmonary Disease-related deaths among adults in the U.S. in 2014, by genderLeading underlying causes of death among COPD deaths in the U.S. in 2014, by gender
- Rate of death from Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2015, by urban-rural status (per 100,000 population)COPD death rate in the U.S. 2015, by urban-rural status
- Risk factor: Smoking
The most important statistics
- Number of current adult smokers in the United States from 1965 to 2016 (in millions)*Number of adult smokers in the United States 1965-2016
- Prevalence of smoking among U.S. adults as of 2018, by ethnicity*U.S. smoking prevalence among adults by ethnicity 2018
- U.S. states with the highest smoking rates among adults in 2017U.S. states with highest adult smoking rates 2017
- Percentage of U.S. adults that used various forms of tobacco products in 2017, by ageU.S. adult tobacco product use in 2017, by age
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Medicines in clinical stage pipeline for diseases in developing countries 2014
- Pharmaceutical products in pipeline for disease in developing countries 2018
- Top companies developing medicines for children in developing countries 2014
- Average per-patient clinical trial costs in U.S. 2013, by selected condition
- Number of biopharmaceutical clinical trials in the U.S. 2013, by selected disease
- Number of medicines in the pipeline in New Zealand 2016, by select disease
- Distribution of active oncology products along the drug pipeline February 2014
- Number of active oncology products along the pipeline in BRIC countries 2014
- U.S. physicians with an opioid marketing payment in 2013-2015, by census region
- Number of opioid marketing payments U.S. in 2013-2015, by census region
- Mean cost of U.S. opioid marketing as of 2015, by census region
- Mean cost of U.S. opioid marketing 2013-2015, by ethnicity
- Physicians with an opioid marketing payment in 2013-2015 U.S., by ethnicity
- Number of opioid marketing payments in the U.S. in 2013-2015, by ethnicity
- Market cap of select pharma companies with strong pipeline 2017
- Romania: pharmaceutical goods import value 2012-2017
- Industry revenue of »manufacture of basic pharmaceutical products« in Austria 2011-2023
- Greece: medicament mixtures put in dosage import value 2012-2017
- Forecast: revenue basic pharmaceutical product manufacture Austria 2008-2020
- Latin America: wound debridement products market value 2018-2023
Studies
- Recent Trends in Hospital Drug Spending and Manufacturer Shortages (2019)
- Meds Entry Watch 2017
- Meds Entry Watch 2016
- Prescribed Drug Spending in Canada, 2018
- Zoetis Annual Report 2018
- Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2...
- Patented Medicine Prices Review Board - Annual Report 2017
- Drug Use Among Seniors in Canada, 2016
- Tackling drug-resistant infections globally: the review on antimicrobial resistance
- Patented Medicine Prices Review Board - Annual Report 2016
- Prescribed Drug Spending in Canada, 2017
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015
- Compass Rx - Annual Public Drug Plan Expenditure Report 2012/13
- Prescription drug access and affordability an issue for nearly a quarter of all Canadian h...
- Prescribed Drug Spending in Canada, 2013
Statistics on "Chronic Obstructive Pulmonary Disease (COPD) in the U.S. "
- Leading causes of death worldwide in 2016 (in millions)
- Number of deaths from Chronic Obstructive Pulmonary Disease worldwide in 2015, by region (in thousands)
- Percentage change in the number of deaths from Chronic Obstructive Pulmonary Disease worldwide from 1990 to 2015, by region
- Number of prevalent cases of Chronic Obstructive Pulmonary Disease worldwide in 2015, by region (in thousands)
- Distribution of global respiratory therapy market by condition in 2017-2018 (in billion U.S. dollars)*
- Number of products in pharmaceutical industry pipeline for selected diseases in developing countries as of 2016
- Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2017, by state
- Percentage of adults in the U.S. who had been diagnosed with Chronic Obstructive Pulmonary Disease as of 2015, by ethnicity
- Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2015, by urban-rural status
- 30-day hospital readmission rates in the U.S. from 2015 to 2017, by selected disease*
- Top 20 respiratory brands in the U.S. based on revenue in 2016 (in million U.S. dollars)
- Percentage of individuals in the U.S. with Chronic Obstructive Pulmonary Disease who experienced select symptoms within the last month as of 2017
- Percentage of individuals in the U.S. with COPD who stated select symptoms were the most challenging/frustrating as of 2017
- Percentage of individuals in the U.S. with Chronic Obstructive Pulmonary Disease who stated it was easy to avoid triggers as of 2017
- Percentage of individuals in the U.S. with Chronic Obstructive Pulmonary Disease who experience incontinence when a flare-up hits as of 2017
- Number of deaths from Chronic Obstructive Pulmonary Disease (COPD) among adults in the U.S. from 2000 to 2014, by gender (per 100,000 population)
- Number of deaths from Chronic Obstructive Pulmonary Disease (COPD) among adults in the U.S. from 2000 to 2014, by ethnicity (per 100,000 population)
- Number of deaths from Chronic Obstructive Pulmonary Disease (COPD) among older adults in the U.S. in 2014, by age and gender (per 100,000 population)
- Distribution of leading underlying causes of death for Chronic Obstructive Pulmonary Disease-related deaths among adults in the U.S. in 2014, by gender
- Rate of death from Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2015, by urban-rural status (per 100,000 population)
- Number of current adult smokers in the United States from 1965 to 2016 (in millions)*
- Prevalence of smoking among U.S. adults as of 2018, by ethnicity*
- U.S. states with the highest smoking rates among adults in 2017
- Percentage of U.S. adults that used various forms of tobacco products in 2017, by age
- Number of products in clinical stage pipeline for selected diseases in developing countries as of 2014
- Distribution of product pipeline for diseases in developing countries by category as of 2018*
- Number of medicines for children being developed by pharmaceutical companies in developing countries as of 2014
- Average biopharmaceutical clinical trial cost per patient in the United States in 2013, by selected condition
- Number of biopharmaceutical industry-sponsored clinical trials in the United States in 2013, by selected disease area
- Number of medicines on the waiting list in New Zealand as of 2016, by select disease
- Share of active oncology products along the drug pipeline as of February 2014
- Number of active oncology products along the pipeline in BRIC countries as of March 2014
- Mean number of U.S. physicians with one or more opioid marketing payments in 2013-2015, by census region (per 1,000 population)*
- Number of opioid marketing payments made to U.S. doctors in 2013-2015, by census region (per 1,000 population)
- Mean cost of U.S. opioid pharmaceutical marketing per 1,000 population in 2013-2015, by census region (in U.S. dollars)
- Mean cost of opioid pharmaceutical marketing per 1,000 U.S. population in 2013-2015, by ethnicity (in U.S. dollars)*
- Number of U.S. physicians with one or more opioid marketing payments in 2013-2015, by ethnicity (per 1,000 population)*
- Number of opioid marketing payments made to U.S. doctors in 2013-2015, by ethnicity (per 1,000 population)*
- Market capitalization of select therapeutic pharmaceutical companies as of 2017 (in billion U.S. dollars)*
- Value of pharmaceutical goods imported to Romania from 2012 to 2017 (in 1,000 euro)
- Industry revenue of »manufacture of basic pharmaceutical products« in Austria from 2011 to 2023 (in million U.S. Dollars)
- Value of medicament mixtures put in dosage imported to Greece from 2012 to 2017 (in 1,000 euros)
- Revenue of basic pharmaceutical product manufacture (NACE Rev. 2 C2110) in Austria from 2008 to 2020 (in million U.S. dollars)
- Wound debridement products market value in Latin America in 2018 and 2023 (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.